EMBC Embecta Corp.

NASDAQ
$5.10

Embecta Corp. (EMBC) is expected to report earnings on November 6, 2026, before the market open. The consensus earnings estimate is $0.31 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +23.2% since its last earnings release on August 7, 2026.

Embecta Beat Consensus Estimates
Friday, August 7, 2026 · 6:30 AM ET
Earnings Date
4th Quarter, Sep 2026
Nov 6
Friday · 6:30 AM ET
Earnings Whisper
-
vs $0.31
Rev est $1.02B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.80

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Embecta Corp.

embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 1 ETFs, by dollar flow